Venlafaxine and cardiovascular toxicity

BMJ (Online)

Volumn 340, Issue 7742, 2010, Pages 327-

  Taylor, David ^a  

^a SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; DOSULEPIN; FLUOXETINE; NORTRIPTYLINE; POTASSIUM CHANNEL; SEROTONIN UPTAKE INHIBITOR; SODIUM CHANNEL; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ARRHYTHMOGENESIS; CARDIOTOXICITY; DEPRESSION; DRUG OVERDOSE; DRUG SAFETY; ELECTROCARDIOGRAPHY; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; LETTER; LOW DRUG DOSE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; QT PROLONGATION; SINGLE DRUG DOSE; SUDDEN DEATH; SUICIDE ATTEMPT;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CYCLOHEXANOLS; DEATH, SUDDEN, CARDIAC; DEPRESSIVE DISORDER; DRUG OVERDOSE; HUMANS; SEROTONIN UPTAKE INHIBITORS;

EID: 76649126230     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c411     Document Type: Letter

References (12)

1. Glassman A. Depression and cardiovascular disease. Pharmacopsychiatry 2008;41:221-5. [CrossRef][Web of Science][Medline]
2. Taylor D. Antidepressant drugs and cardiovascular pathology: a clinical overview of effectiveness and safety. Acta Psychiatr Scand 2008;118:434-42.[CrossRef][Web of Science][Medline]
3. Martinez C, Assimes TL, Mines D, Dell'Aniello S, Suissa S. Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near-death: a nested case-control study. BMJ 2010;340:c249.[Abstract/Free Full Text]
4. Khalifa M, Daleau P, Turgeon J. Mechanism of sodium channel block by venlafaxine in guinea pig ventricular myocytes. J Pharmacol Exp Ther 1999;291:280-4.[Abstract/Free Full Text]
5. Fossa AA, Gorczyca W, Wisialowski T, Yasgar A, Wang E, Crimin K, et al. Electrical alternans and hemodynamics in the anesthetized guinea pig can discriminate the cardiac safety of antidepressants. J Pharmacol Toxicol Methods 2001;55:78-85.[CrossRef]
6. Buckley NA, McManus PR. Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data. BMJ 2002;325:1332-3.[Free Full Text]
7. Whyte IM, Dawson AH, Buckley NA. Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. Q J Med 2003;96:369-74.[Web of Science]
8. Howell C, Wilson AD, Waring WS. Cardiovascular toxicity due to venlafaxine poisoning in adults: a review of 235 consecutive cases. Br J Clin Pharmacol 2007;64:192-7.[CrossRef][Medline]
9. White N, Litovitz T, Clancy C. Suicidal antidepressant overdoses: a comparative analysis by antidepressant type. J Med Toxicol 2008;4:238-50.[CrossRef][Medline]
10. Mines D, Hill D, Yu H, Novelli L. Prevalence of risk factors for suicide in patients prescribed venlafaxine, fluoxetine, and citalopram. Pharmacoepidemiol Drug Saf 2005;14:367-72.[CrossRef][Web of Science] [Medline]
11. Taylor D, Scott JR. Volte-face on venlafaxine-reasons and reflections. J Psychopharmacol 2006;20:597-601.[Free Full Text]
12. Medicines and Healthcare Products Regulatory Agency. Venlafaxine (Efexor) summary of basis for regulatory position. 2006. www.mhra.gov.uk/home/idcplg? IdcService=GET-FILE& dDocName=CON2023840&RevisionSelectionMethod= LatestReleased.